Centro de Investigación Biomédica en Red de Enfermedades Infecciosas-ko ikertzaileekin lankidetzan egindako argitalpenak (3)

2023

  1. Academia and industry agreement on a feasibility tool for first-time-in-human clinical trial units

    Clinical and Translational Science, Vol. 16, Núm. 12, pp. 2421-2428

2022

  1. Immune response and reactogenicity after immunization with two-doses of an experimental COVID-19 vaccine (CVnCOV) followed by a third-fourth shot with a standard mRNA vaccine (BNT162b2): RescueVacs multicenter cohort study

    eClinicalMedicine, Vol. 51

  2. Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study

    eClinicalMedicine, Vol. 50